Successful treatment of COVID-19-related acute respiratory distress syndrome with rare blood type: A case report
Hiroyuki Yamada, MD1,2, Shigeru Ohtsuru, MD1, Mika Nagatomo, MD1, Yohei Korogi, MD3, Ken Shinozuka, MD1, Naoya Tanabe, MD3, Shinichi Kai, MD4, Takeshi Matsubara, MD2,
Isao Ito, MD3, Masahiro Ihara, MD5, Tomoharu Tanaka, MD4, Genta Kato, MD6,
Miki Nagao, MD7, Hiroshi Date, MD8
1Department of Primary Care and Emergency Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
2Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3Department of Reparatory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
4Department of Anesthesia, Graduate School of Medicine, Kyoto University, Kyoto, Japan
5Department of Medical Informatics, Graduate School of Medicine, Kyoto University, Kyoto
6Solutions Center for Health Insurance Claims, Kyoto University Hospital
7Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
8Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Keywords: ECMO, Rhesus, hydrocortisone, COVID-19, ARDS, AKI
*Correspondence: Shigeru Ohtsuru, MD, PhD
54 Shogoin-kawaharacho, Sakyo-ku, Kyoto 6068507, Japan
Phone: +81-75-751-3126
Fax: +81-75-751-4255
Email: ohtsuru@kuhp.kyoto-u.ac.jp